Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes

Journal of the Neurological Sciences

Volumn 155, Issue 1, 1998, Pages 23-30

  Terada, Masahiko ^a   Yasuda, Hitoshi ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Axonal degeneration; Diabetic neuropathy; Macrophage; Neurofilaments; Phosphorylation; Walterian degeneration

Indexed keywords

CALPAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NERVE FIBER DEGENERATION; NERVE FIBER TRANSECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE DIAGNOSIS; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

ANIMALS; CELL MOVEMENT; DIABETES MELLITUS, EXPERIMENTAL; MACROPHAGES; MALE; NEUROFILAMENT PROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; WALLERIAN DEGENERATION;

EID: 0032542509     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00269-4     Document Type: Article

References (29)

1. Beuche W., Friede R.L. The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13:1984;767-796.
2. Bisby M.A., Chen S. Delayed Wallerian degeneration in sciatic nerves of C57BL/Ola mice is associated with impaired regeneration of sensory axons. Brain Res. 530:1990;117-120.
3. Dijkstra C.D., Doepp E.A., Jolin P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 54:1985;589-599.
4. Ekstrom P.A.R., Tomlinson D.R. Impaired nerve regeneration in streptozocin-diabetic rats. Effect of treatment with an aldose reductase inhibitor. J. Neurol. Sci. 93:1989;231-237.
5. Elhanany E., Jaffe H., Link W.T., Sheeley D.M., Gainer H., Pant H.C. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein. J. Neurochem. 63:1994;2324-2335.
6. Glass J.D., Brushart T.M., George E.B., Griffin J.W. Prolonged survival of transected nerve fibers in C57BL/Ola mice is an intrinsic characteristic of the axon. J. Neurocytol. 22:1993;311-321.
7. Griffin, J.W., Hoffman, P.N., 1993. Degeneration and regeneration in the peripheral nervous system. In: Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A., Poduslo, J.F. (Eds.), Peripheral Neuropathy, 3rd ed., vol. 1. Saunders, Philadelphia PA, pp. 361-376.
8. Hisanaga S., Hirokawa N. Structure of the peripheral domains of neurofilaments revealed by low angle rotary shadowing. J. Mol. Biol. 202:1988;297-305.
9. Hoffman P.N., Griffin J.W., Price D.L. Control of axonal caliber by neurofilament transport. J. Cell Biol. 99:1984;705-714.
10. 2+-activated neutral proteases in the peripheral nerve and its effects on neurofilament degeneration. J. Neurochem. 40:1983;908-913.
11. Lee M.K., Xu Z., Wong P.C., Cleaveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122:1993;1337-1350.
12. Lefebre S., Mushynski W.E. Calcium binding to untreated and dephosphorylated porcine neurofilaments. Biochem. Biophys. Res. Commun. 145:1987;1006-1011.
13. Longo F.M., Powell H.C., Lebeau J., Gerrero M.R., Heckman H., Myers R.R. Delayed nerve regeneration in streptozotocin diabetic rats. Muscle Nerve. 9:1986;385-393.
14. Medri R., Autilio-Gambetti L., Monaco S., Gambetti P. Experimental diabetic neuropathy: Impairment of slow transport with changes in axon cross-sectional area. Proc. Natl. Acad. Sci. USA. 82:1985;7716-7720.
15. Medri R., Autilio-Gambetti L., Jenich H., Gambetti P. Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology. 38:1988;597-601.
16. Mohiuddin L., Fernyhough P., Tomlinson D.R. Reduced levels of mRNA encording endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes. Diabetes. 44:1995;25-30.
17. Pant H.C. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem. J. 256:1988;665-668.
18. Pekiner C., McLean W.G. Neurofilament protein phosphorylation in spinal cord of experimentally diabetic rats. J. Neurochem. 56:1991;1362-1367.
19. Reichert F., Saada A., Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J. Neurosci. 14:1994;3231-3245.
20. Schlaepfer W.W., Micko S. Chemical and structural changes of neurofilaments in transected rat sciatic nerve. J. Cell Biol. 78:1978;369-378.
21. Shea T.B., Paskevich P.A., Keermann M.L. The protein phosphatase inhibitor okadaic acid increases axonal neurofilaments and neurite caliber, and decreases axonal microtubules in NB2a/d1 cells. J. Neurosci. Res. 35:1993;507-521.
22. Shetty K.T., Link W.T., Pant H.C. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterization. Proc. Natl. Acad. Sci. USA. 90:1993;6844-6848.
23. Sima A.A.F., Bril V., Nathaniel V.et al. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients 18 with diabetic neuropathy treated with sorbinil. New Engl. J. Med. 319:1988;548-555.
24. Terada M., Yasuda H., Kikkawa R. Tolrestat improves nerve regeneration after crush injury in streptozocin-induced diabetic rats. Metabolism. 45:1996;1189-1195.
25. Thomas O.C., Hsieh S.-T., Schryer B.L., Glass J.D. Prolonged axonal survival in transected nerves of C57BL/Ola mice is independent of age. J. Neurocytol. 24:1995;333-340.
26. Triban C., Guidolin D., Fabris M.et al. Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes. 38:1989;1012-1022.
27. Veernna K., Shetty K.T., Link W.T., Jaffe H., Wang J., Pant H.C. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64:1995;2681-2690.
28. Wolf B.A., Williamson J.R., Eason R.A., Chang K., Sherman W.R., Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose level. J. Clin. Invest. 87:1990;31-38.
29. Yang S.D., Huang J.J., Huang T.J. Protein kinase FA/Glycogen synthase kinase 3a predominantly phosphorylates the in vivo sites of Ser502, Ser506, Ser603, and Ser666 in neurofilament. J. Neurochem. 64:1995;1848-1854.